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Irma Virant-Klun1*, Martin Stimpfel1, Branko Cvjeticanin1, Eda Vrtacnik-Bokal1 and Thomas Skutella2Abstract
Background: It has already been found that very small embyronic-like stem cells (VSELs) are present in adult
human tissues and organs. The aim of this study was to find if there exists any similar population of cells in cell
cultures of reproductive tissues and embryonic stem cells, and if these cells have any relation to pluripotency and
germinal lineage.
Methods and results: Here we report that a population of small SSEA-4-positive cells with diameters of up to
4 μm was isolated by fluorescence-activated cell sorting (FACS) from the human ovarian cell cultures after
enzymatic degradation of adult cortex tissues. These small cells – putative ovarian stem cells – were also observed
during cell culturing of up to 6 months and more. In general, small putative ovarian stem cells, isolated by FACS,
showed a relatively low gene expression profile when compared to human embryonic stem cells (hESCs) and
human adult fibroblasts; this may reflect the quiescent state of these cells. In spite of that, small putative ovarian
stem cells expressed several genes related to primordial germ cells (PGCs), pluripotency and germinal lineage,
including VASA. The PGC-related gene PRDM1 was strongly expressed in small putative ovarian stem cells; in both
hESCs and fibroblasts it was significantly down-regulated. In addition, putative ovarian stem cells expressed other
PGC-related genes, such as PRDM14 and DPPA3. Most of the pluripotency and germinal lineage-related genes were
up-regulated in hESCs (except VASA). When compared to fibroblasts, there were several pluripotency-related genes,
which were up-regulated in small putative ovarian stem cells. Similar populations of small cells were also isolated
by FACS from human testicular and hESC cultures.
Conclusions: Our results confirm the potential embryonic-like character of small putative stem cells isolated from
human adult ovaries and their possible relation to germinal lineage.
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At the beginning it was supposed that pluripotent hu-
man embryonic stem cells (hESCs) can be isolated only
from the human embryo, but later it was found that
embyronic-like stem cells are also present in adult human
tissues and organs. The group of Ratajczak first found a
novel population of CXCR4+, SSEA-1+, Oct-4+ and
CD45- cells in adult bone marrow [1,2] and CXCR4+,
SSEA-4+, and Oct-4+ cells in umbilical blood [3]. Because
these cells were small and round, with diameters of up to* Correspondence: irma.virant@gmail.com
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distribution, and reproduction in any medium~5–6 μm, they termed them very small embryonic-like
stem cells (VSELs). They hypothesized that these cells are
deposited early during development in bone marrow as a
mobile pool of circulating pluripotent stem cells that play
a crucial role in postnatal tissue turnover and regener-
ation, both of non-hematopoietic and hematopoietic tis-
sues. Indeed, bone marrow-derived pluripotent VSELs are
mobilized into peripheral blood after acute myocardial in-
farction [4,5], stroke [6], skin burn injury [7], and Crohn’s
disease [8]. Adult bone marrow and umbilical cord blood
VSELs, expressing the same and other markers of
pluripotency (i.e. NANOG, SOX-2), have been confirmed
by several other groups [9-15]. Moreover, adult human
ovaries offer evidence of cells comparable to VSELstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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thelium, namely, and were also proposed for adult human
testicles [20-22].
During early development, epiblast/germline-derived
cells including primordial germ cells (PGCs) become
founder populations of pluripotent stem cells, which are
deposited during embryogenesis in various organs and
possibly persist as VSELs in these locations into adult-
hood [23]. Molecular analysis of purified VSELs revealed
the expression of several epiblast/PGC markers, migrat-
ing PGC-like epigenetic reprogramming profiles of Oct4,
Nanog and Stella loci and unique patterns of genomic
imprinting [24]. It has been demonstrated that VSELs
show hypomethylation or erasure of imprints in pater-
nally methylated genes and hypermethylation of imprints
in maternally methylated genes [25]. All these epigenetic
characteristics lead to the up-regulation of genes H19
and P57 (KIP2 or CDKN1C), and repression of IGF2 and
RASGRF1. This may explain the VSEL’s quiescent status
and lack of teratoma formation in adult tissues and or-
gans. Open chromatin structure of core pluripotency
transcription factors supports the pluripotent state of
VSELs. Like in other pluripotent stem cells, it has been
suggested that VSELs maintain their pluripotent state
through an Ezh2-dependent BD-mediated epigenetic
mechanism based on genome-wide gene-expression ana-
lysis of a small number of highly purified murine bone
marrow-derived Oct4-positive VSELs [26].
We were interested to find if there exists any similar
population of cells in cell cultures of reproductive tissues
and embryonic stem cells, and if these cells have any re-
lation to pluripotency and germinal lineage. We report
that small, SSEA-4-positive putative ovarian stem cells
were isolated from the ovarian cell cultures. These cells
expressed several genes related to pluripotency, embry-
onic development and germinal lineage, and were similar
to those isolated from testicular and embryonic stem cell
cultures.
Material and methods
This study was confirmed by the Slovenian Medical Eth-
ical Committee (Ministry of Health of the Republic of
Slovenia, No. 135/09/09 and 154/07/10). Ovarian cortex
tissue was surgically retrieved as small biopsies in five
patients for different gynecological reasons (non-ovarian
cancer, removal of ovaries to prevent breast cancer, my-
oma or cyst removal). Testicular tissue was retrieved in
two infertile men with azoospermia (no sperm in the
ejaculate) at diagnostic testicular biopsy to retrieve
sperm for in vitro fertilization treatment; in both pa-
tients there was no sperm in their testicular tissue due
to Sertoli Cell-Only Syndrome (SCOS) or maturation ar-
rest (MA). Each patient’s tissue was used for a research
purpose after clear explanation of the study and writtenconsent to participate. One cell culture was established
from each ovarian or testicular biopsy. Frozen hESCs of
the H1 line (37th passage) were provided from abroad
for research purposes only. All cell cultures were
established at the University Medical Centre Ljubljana.
Enzymatic degradation of ovarian cortex or testicular
tissues
Ovarian cortex tissue or frozen-thawed testicular tissue
(two ampoules per patient) of up to 4 mm3, retrieved via
biopsy, was enzymatically degraded in the same way.
The tissue was transferred into a warm, pre-incubated
Dulbecco’s Modified Eagle’s Medium (DMEM)/Nutrient
Mixture F-12 Ham with L-glutamine and 15 mM HEPES
(D8900; Sigma Aldrich, St. Louis, MO, USA), supple-
mented with 3.7 g/L NaHCO3, 1% penicillin/strepto-
mycin (Sigma Aldrich), and pH adjusted to 7.4 with 1 M
NaOH. The whole ovarian/testicular tissue was enzymati-
cally degraded in two steps, as described previously [22].
In the first step it was degraded with collagenase type XI
(0.5 mg/mL) and in the second step with collagenase type
XI (0.5 mg/mL) and prepared hyaluronidase (SynVitro
Hydase; Origio, Måløv, Denmark). After 10 minutes of in-
cubation at 37°C in each enzyme solution, 20% fetal bo-
vine serum (FBS) was added to inactivate enzymes. The
suspension of cells was passed through a 70 μm cell
strainer (BD Falcon; BD Biosciences, San Jose, CA, USA)
and centrifuged for 8 minutes at 1,500 rpm. After centrifu-
gation the supernatant was removed, and the pellets were
resuspended in culture medium and placed in the culture
dishes.
Culture of ovarian, testicular and embryonic stem cells
After enzymatic degradation the ovarian or testicular tis-
sue cells were cultured in two different culture media: 1)
DMEM/F-12 culture medium with 3.7 g/L NaHCO3, 1%
penicillin/streptomycin (Sigma Aldrich), pH adjusted to
7.4 with 1 M NaOH and with added 20% (v/v) fetal bo-
vine serum (FBS), on gelatine as the supporting layer or 2)
hESC culture medium of DMEM/F-12 medium, including
20% KnockOut Serum Replacement (Gibco Life Tech-
nologies, Carlsbad, CA, USA), 1 mM L-glutamine (PAA,
Pasching, Austria), 1% nonessential amino acids (PAA),
0.1 mM 2-mercaptoethanol (Invitrogen Life Technologies,
Carlsbad, CA, USA), 13 mM HEPES, and 4 ng/mL human
basic FGF (Sigma Aldrich), on matrigel as the supporting
layer. Ovarian cells and hESCs were cultured in twelve-
well culture plates and testicular cells in four-well plates.
Cells were cultured in a CO2-incubator at 37°C and 6%
CO2 in air for approximately three months (3.5, 4, 1, 1
and 3.5 months in five ovarian cell cultures and 1 and
3 months in two testicular cultures). In each culture the
cells and colonies they formed were monitored daily under
a heat-stage equipped inverted microscope at Hoffman or
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tion (Eclipse T-2000; Nikon, Tokyo, Japan – equipped with
a Nikon Digital Sight Camera).
Immunocytostaining on the expression of surface antigen
SSEA-4, nuclear OCT4, SOX-2 and VASA germinal marker
Cells were fixed in 4% paraformaldehyde and perme-
abilized with 0.2% Triton and then incubated with 3%
H2O2 for 10 minutes to block the endogenous peroxidase
activity and for 20 minutes with 10% FBS to block the
nonspecific binding sites. Then the cells were incubated
for 1 hour at room temperature with rabbit anti-VASA
primary antibody (diluted 1:500; Millipore) or mouse anti-
SOX2 monoclonal antibody (diluted 1:100, Abcam). After
washing with phosphate-buffered saline (PBS), the cells
were incubated with biotinylated secondary antibodies,
polyclonal goat anti-rabbit immunoglobulins (diluted
1:600; Dakocytomation, Glostrup, Denmark) or polyclonal
rabbit anti-mouse immunoglobulins (diluted 1:400;
Dakocytomation), for 30 minutes and then with an ABC
reagent (Vectastain ABC Kit-Standard; Vector Laboratories,
Burlingame, CA, USA) for 30 minutes. Finally, the cells
were incubated in a DAB substrate (Sigma Aldrich) until
brown staining appeared (but no longer than 5 minutes),
washed with PBS and observed under an inverted micro-
scope (Hoffman illumination) to detect positive brown-
stained cells or cell colonies. Immunofluorescence was
used to detect the expression of OCT4 and also SSEA-4.
Briefly, cells were fixed in 4% paraformaldehyde, perme-
abilized with 0.2% Triton (for OCT4) and incubated for
20 minutes with 10% FBS. Then the cells were incubated
for 1 hour with polyclonal rabbit anti-OCT4 primary
antibodies (diluted 1:100; Stemgent, Boston, MA, USA)
or mouse anti-stage-specific embryonic antigen-4
(SSEA-4) monoclonal antibody (clone MC-813-70, di-
luted 1:100; Millipore, MA, USA) and after washing, again
for 30 minutes with Cy3 goat anti-rabbit secondary anti-
bodies (diluted 1:200; Invitrogen) or with anti-mouse im-
munoglobulins conjugated to Alexa Fluor 488 (1:200;
Molecular Probes). After washing the cells were mounted
using Vectashield mounting medium with DAPI and ob-
served under a fluorescence microscope. For a negative
control, the primary antibodies were omitted from the
procedure and replaced with 1% FBS.
Alkaline phosphatase staining
To detect alkaline phosphatase (AP) activity an Alkaline
Phosphatase Detection Kit (Millipore) was used. Cells
were fixed in 4% paraformaldehyde for 3 minutes and
then incubated in a working solution of reagents which
consisted of Fast Red Violet, Naphtol AS-BI phosphate
solution and water in a 2:1:1 ratio. After 15 minutes the
cells were rinsed with PBS and observed under an
inverted microscope (Hoffman illumination). The cellsor cell colonies expressing AP activity were stained pink
to red.Fluorescence-activated cell sorting (FACS)
Cells from one twelve-well plate of each culture were
trypsinized (0.15% solution of trypsin-EDTA) and sorted
based on SSEA-4 expression. The SSEA-4-positive cells
were isolated from a cell suspension of each cell culture
using fluorescence-activated cell sorting (FACSAria, BD
Biosciences, San Jose, CA, USA). Briefly, 106 cells were
resuspended in PBS with 1% penicillin/streptomycin
(Sigma Aldrich) and stained with anti-SSEA-4 antibodies
(clone MC813-70; BD Pharmingen, San Jose, CA, USA)
conjugated with phycoerythrin (PE). The sample stained
with an appropriate isotype control (PE Mouse IgG3, κ;
BD Pharmingen) was examined in parallel. All antibodies
were added at saturation concentrations, and the cells
were incubated for 30 minutes in the dark, then washed
and resuspended for sorting in PBS with penicillin/
streptomycin at a concentration of 2 × 106 cells/ml. Sorted
cells were collected in Dulbecco’s Modified Eagle’s
Medium (DMEM)/Nutrient Mixture F-12 Ham with
L-glutamine and 15 mM HEPES (D8900; Sigma Aldrich),
supplemented with 3.7 g/L NaHCO3 (S5761; Sigma
Aldrich), 1% penicillin/streptomycin, 0.5% gentamycin
(G1272; Sigma Aldrich) and pH adjusted to 7.4 with 1 M
NaOH. After FACS cells were cultured in DMEM/F-12
culture medium with 20% fetal bovine serum. Droplets of
sorted cells were DAPI stained and monitored under a
fluorescence microscope.Gene expression analyses by microarrays
Three samples of populations of SSEA-4-positive puta-
tive ovarian stem cells (OSC), isolated by FACS from
three different ovarian cell cultures in three different pa-
tients were analyzed by microarrays and compared with
positive control – three samples of hESCs (ESC) of H1
cell line (WiCell, WI, USA), and negative control – three
samples of human adult (dermal) fibroblasts (FB). Sam-
ples were lysed using SuperAmp™ Lysis Buffer and
stored at -20°C. When collected, the samples were ana-
lyzed by Miltenyi Biotec (Bergisch Gladbach, Germany)
according to established protocols. First the SuperAmp
RNA amplification was performed. Amplified cDNA sam-
ples were quantified using the ND-1000 Spectrofotometer
(NanoDrop Technologies, Wilmington, DE, USA). The in-
tegrity of cDNA was checked via the Agilent 2100
Bioanalyzer platform (Agilent Technologies, Wokingham,
UK). The Cy3-labeled cDNAs were hybridized overnight
to an Agilent Whole Human Genome Oligo Microarrays
8×60K and washed. Fluorescence signals of the hybridized
Agilent Microarrays were detected using Agilent’s Micro-
array Scanner System (Agilent Technologies). The Agilent
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process the microarray image files.
Statistics of microarray analyses
Two differential gene expression analyses (DGAs) were
performed: hESCs vs. OSCs (FACS-isolated SSEA-4-
positive small putative ovarian stem cells) and fibroblasts
vs. OSCs (FACS-isolated SSEA4-positive small putative
ovarian stem cells) to identify differently expressed tran-
scripts. For determination of differential gene expression
(DGA) derived output data files were further analyzed
using the Rosetta Resolver gene expression data analysis
system (Rosetta Biosoftware). Data were preprocessed by
normalization and correlation analysis. The normalized
intensities were log2-transformed and served as basis for
further analysis. Heatmaps were created based on ratio
data in log2 space to get a more intuitive visual in-
spection of gene expression data. A Student’s t-test
was performed on each gene separately using norma-
lized log2 intensity data. Statistical significance was set
at p < 0.05. The genes selected as reliable candidates
for differentially expressed genes were required to
show at least a 16-fold average expression difference
(log ratio = 4) between the sample groups. Due to some
variability, a more stringent selection was performed for the
individual comparisons to get a statistically high confidence
list of differently expressed genes. To elucidate the gene
functions and pathways IPA Software was used (IngenuityFigure 1 Cell colonies formed in ovarian (O), testicular (T) and human
Scale bar: 50 μm.Systems, Redwood City, CA, USA). We focused on genes
related to primordial germ cells, pluripotency and germi-
nal lineage, and genes up-regulated or down-regulated in
putative ovarian stem cells in comparison with other
groups of cells (hESCs and fibroblasts).
RT-PCR analyses
The samples remained after microarray analyses were
analyzed by RT-PCR. Gene expression analyses of three
samples of putative ovarian stem cells (OSC1-3) were
performed using the Biomark Real-Time quantitative PCR
(qPCR) system (Fluidigm, San Francisco, CA, USA). In all
samples, expressions of 7 genes: LEFTY1, SALL4, OCT4A,
TDGF1, REC8, CDH1 and STELLA, related to pluri-
potency and embryonic stem cells, and of the housekeep-
ing gene GAPDH, which was used for normalization, were
analyzed in comparisons with three samples of positive
control – hESCs (ESC1-3), and three samples of negative
control – human adult (dermal) fibroblasts (FB1-3). The
inventoried TaqMan assays (20×, Applied Biosystems,
Carlsbad, CA, USA) were pooled to a final concentration
of 0.2× for each of the 8 assays. The samples were put dir-
ectly into 9 μL RT-PreAmp Master Mix (5.0 μL
CellsDirect 2× Reaction Mix (Invitrogen); 2.5 μL 0.2×
assay pool; 0.2 μL RT/Taq Superscript III (Invitrogen);
1.3 μL TE buffer). The sequencespecific reverse transcrip-
tion was performed at 50°C for 15 minutes. The reverse
transcriptase was inactivated by heating to 95°C forembryonic stem cell (E) cultures under inverted microscope.
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through limited sequence-specific amplification by de-
naturing at 95°C for 15 seconds, and annealing and am-
plification at 60°C for 4 minutes for 14 cycles. These
pre-amplified products were diluted 5-fold prior to ana-
lysis with Universal PCR Master Mix and the inventoried
TaqMan gene expression assays (ABI) in 96.96 Dynamic
Arrays on a BioMark System. Each sample was analyzed
in two technical replicates. Ct values were obtained from
the BioMark System and were transferred to the GenEx
software (MultiD, Göteborg, Sweden). The compared
groups of samples were analyzed on heatmap and hier-
archical clusterings (Ward’s Algorithm, Euclidean DistanceFigure 2 Small, round, yellow-coloured cells with diameters of up to
as single cells. In ovarian (O), testicular (T) and early human embryonic ste
bars: 50 μm and 10 μm.Measure) and by principal component analysis (PCA). In
addition, descriptive statistics were calculated individually
for the genes using a 0.95% confidence level and groups of
cells (OSCs vs. hESCs and OSCs vs. fibroblasts FBs) were
compared by an unpaired 2-tailed Student’s T-test; to keep
the overall risk of error at 0.05 a threshold value of
0.00730 was used according to the Dunn-Bonferoni
correction.
Results
In all cell cultures comparable cell colonies were devel-
oped (Figure 1). Cell colonies in ovarian and testicular
cell cultures were similar, and were quite comparable to4 μm – putative stem cells – forming cell colonies or appearing
m (E) cell cultures after thawing, under an inverted microscope. Scale
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all cell cultures, small, round, yellow-coloured cells with
diameters of up to 4 μm and with very similar morph-
ology were observed among other cell types (Figure 2).
These cells were not blood cells or cells from the im-
munological system, as previously confirmed by May-
Grünwald-Giemsa staining [18]. Also, they were not
lipid droplets, because they did not stain by Oil Red O
(data not shown).
In ovarian and testicular cell cultures these small,
round, yellow-coloured cells were more abundant when
cultured in hESC culture medium than in DMEM/F-12
culture medium with added FBS. They were appearing
throughout the entire cell culturing process. At some
places it was clearly seen that they formed cell colonies
or were present around them (Figure 2). These small
cells were appearing as single cells or were attached to
other types of cells (Figure 3). They showed a high affin-
ity to other types of cells (e.g. fibroblasts, epithelial cells)
and were mostly attached to them. In hESC cultures
these cells were more abundant in early cell cultures,
establishing after thawing the cells, but were also present
in an established cell culture with typical, well-developed
cell colonies. In testicular stem cell cultures these small
round cells were attached to different male germinal cells
(e.g. spermatogonia, spermatocytes, round spermatids),Figure 3 Small, round, yellow-coloured cells (arrows) – putative
stem cells – with diameters of up to 4 μm: from testicular (T)
cell cultures (attached to germinal cells, Sertoli cells or
fibroblasts) or from ovarian (O) cell cultures (attached to
epithelial or other types of cells). DAPI (blue) stained nuclei from
ovarian (O) cell cultures. Scale bars: 10 μm.Sertoli cells or fibroblasts (Figure 3). In ovarian cell cul-
tures they were also attached to bigger cells (e.g. epithelial
cells, fibroblasts) (Figure 3). After DAPI staining these
small cells exhibited high nucleus/cytoplasm ratios
(Figures 3 and 4).
SSEA-4-positive cells sorted by FACS
The mean duration of cell cultures at the time of FACS
was 2.6 months (min. 1 – max. 4) for ovarian cell cul-
tures and 2 months (1 month and 3 months) for testicu-
lar cell cultures. After trypsinisation of ovarian, testicular
and embryonic stem cell cultures, a very similar popula-
tion of SSEA-4-positive cells was isolated from each cul-
ture by FACS, as can be seen in Figure 5. These cells
were predominately small, round, yellow-coloured cells
with diameters of up to 4 μm. Like during culturing,
these cells were appearing as single cells or were at-
tached to bigger cells (Figure 5). When observed after
immunofluorescence staining, these cells were con-
firmed to be SSEA-4-positive (Figure 6). The expression
of surface antigen SSEA-4, an established marker of
pluripotency [27], makes them putative stem cells. In one
testicular and one hESC culture some of the sorted small,
round, yellow-coloured cells – putative stem cells – grew
and developed into cells with diameters of up to 10 μm
(Figure 5). The SSEA-4-positive cells represented 2.2% ofFigure 4 DAPI stained (blue) nuclei (arrows) of small putative
stem cells from ovarian (O), testicular (T) and human
embryonic stem (E) cell cultures. Scale bars: 100 μm.
Figure 5 SSEA-4-positive cells – putative stem cells – isolated by fluorescence-activated cell sorting (FACS) from ovarian (O), testicular
(T) and human embryonic stem (E) cell cultures were small, round, yellow-coloured cells with diameters of up to 4 μm. They appeared
as single cells or were attached to bigger cells. In one ovarian (O) cell culture and one (T) testicular cell culture these small cells were proliferating
(long arrows) or growing into bigger round cells (short arrows) with diameters of up to 10 μm. Scale bars: 10 μm.
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tures, 1.4% of cells on average when sorted from the tes-
ticular cell cultures and 0.8% of cells when sorted from
hESC cultures. The population of putative stem cells
sorted from the hESC culture was very similar to thosesorted from reproductive tissues, as can be seen in
Figure 5. The SSEA-4-positive small, round cells – puta-
tive stem cells – sorted by FACS (Figure 7) were quite
comparable to VSELs in terms of their morphology and
diameters.
Figure 6 Small round cells – putative stem cells – in ovarian cell cultures were SSEA-4 and OCT4-positive (arrows) after
immunofluorescence staining. Merged, SSEA-4 (green), OCT4 (red) and DAPI (blue) stainings are presented for samples and for a
negative control (NC). Scale bars: 10 μm.
Virant-Klun et al. Journal of Ovarian Research 2013, 6:24 Page 8 of 19
http://www.ovarianresearch.com/content/6/1/24Positivity for OCT4, SOX-2 and alkaline phosphatase activity
When in the ovarian cell culture, these small cells were
OCT4-positive, as revealed by immunofluorescence
(Figure 6) and were positively stained on alkaline phos-
phatase (AP) acitivity (Figure 8). In addition, these smallFigure 7 Fluorescence-activated cell sorting of SSEA-4-positive small
embryonic stem (E) cell cultures. Sorted cells are in the marked frames. (cells were present in a hESC culture with typical, well-
developed cell colonies (Figure 9). After immunocytostain-
ing for the SOX-2 marker of pluripotency, a proportion of
these small putative stem cells were positively stained
(Figure 9).putative stem cells from the ovarian (O), testicular (T) and human
A, C, E) Isotype controls. (B, D, F) Samples.
Figure 8 Small putative stem cells in ovarian and testicular cell
cultures were positively stained (arrows) on alkaline phosphatase
(AP). Scale bars: 10 μm. Legend: AP (red) – alkaline phosphatase
activity; NC – negative control.
Figure 10 A proportion of cell colonies and small putative stem
cells in ovarian (O), testicular (T) and human embryonic stem
(E) cell cultures were VASA-positive in comparison with
negative controls (NC) under an inverted microscope. Scale bars:
50 μm and 10 μm.
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Surprisingly, a low proportion of the small round
cells – putative stem cells – and only some of the
cell colonies formed in all cell cultures, including
hESCs, were VASA-positive (Figure 10), as revealed byFigure 9 Small putative stem cells (arrows) in ovarian and
testicular cell cultures were positively stained on alkaline
phosphatase (AP). A proportion of small putative stem cells were
SOX-2 positive. Scale bars: 100 μm (A, D); 50 μm (B, E); 10 μm (C, F).immunocytochemistry, thus showing the possible relation
to the germ lineage.Microarray analyses of small putative ovarian stem cells
in comparison with hESCs and human adult fibroblasts
General gene expression profile
When hESCs were compared to FACS-sorted SSEA-4-
positive putative ovarian stem cells with diameters of up
to 4 μm by Agilent Whole Genome Oligo Microarrays, it
was confirmed that 33,316 genes were unchanged, 5,027
genes were down-regulated and 4,062 genes were up-
regulated in hESCs (Figure 11). The comparison of fibro-
blasts and ovarian stem cells showed a higher difference:
27,182 genes were unchanged, 7,149 genes were down-
regulated and 8,074 genes were up-regulated in fibro-
blasts. In spite of the comparable cDNA concentrations to
be analyzed (hESCs: 174.4, 175.6 and 208.5 ng/μL; puta-
tive ovarian stem cells: 255.1, 180.2 and 189.5 ng/μL; fi-
broblasts: 232.0, 254.9, and 206.2 ng/μL), the overall
intensity distribution of samples with SSEA-4-positive pu-
tative ovarian stem cells was lower than for hESCs and fi-
broblasts and may reflect a more quiescent state.Expression of genes related to pluripotency
The FACS-sorted SSEA-4-positive small putative ovarian
stem cells expressed several genes related to pluripotency,
cell self-renewal, embryonic development and implant-
ation, such as POU5F1 (OCT4), SALL4, CDH1, LIN28B,
Figure 11 Gene expression profile of human embryonic stem cells (10_11_12) in comparison with FACS-sorted SSEA-4-positive small
putative ovarian stem cells (4_5_6). The signal intensities of each feature represented by a dot are shown in a double logarithmic scale. X-axis:
control-log signal intensity; Y-axis: sample-log signal intensity. Legend: Red diagonal lines – the areas of 2-fold differential signal intensities; Blue
cross – unchanged genes; Red cross – significantly up-regulated genes (p-value < 0.01); Green cross – significantly down-regulated genes
(p-value < 0.01); Grey cross – summary of significantly up- and down-regulated signatures.
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ZIC3, ZIC5, PRDM14, GAL, PPP1R9A, RNF2, LASS1
(CERS1), SMO, MMP25, GULP1, MLLT4, BMP7, MYBL2,
DNMT3B, ZFP42, HESRG, ZSCAN10, TRO, GLI2, FBN3
and DDX11. In comparison to hESCs, all these genes were
up-regulated in hESCs, as can be seen in Figures 12 and
13, Additional file 1: Table S1. The most expressed pluri-
potency and embryogenesis-related genes in hESCs were
ZIC3, ZFP42 and HESRG and in small putative ovarian
stem cells HESRG, ZIC3 and LIN28B. The three samples
of FACS-isolated SSEA-4-positive small putative ovarian
stem cells were heterogenous; two samples more strongly
expressed the genes related to pluripotency than the third
sample, as can be seen in Figures 12 and 13. On the other
hand, these genes were not expressed or were only weakly
expressed in human adult fibroblasts (Figure 13). When
these two samples of small putative ovarian stem cells with
more expressed pluripotency were compared to fibro-
blasts, there were several pluripotency and embryogenesis-
related genes which were with statistical significance
up-regulated in small putative ovarian stem cells, such
as SALL4, CDH1, LIN28B, SOX11, LEFTY1, ZIC3,
PRDM14, PPP1R9A, MYBL2, DNMT3B and HESRG
(Table 1). On the other hand, there was one gene –
MMP25 – down-regulated in small putative ovarian stem
cells. The expression of genes related to pluripotency was
not detected in the whole trypsinized ovarian cell culture,
which included an abundant autologous ovarian fibroblast
layer (Figure 12).Expression of genes related to primordial germ cells
Microarray analysis showed that the primordial germ
cell (PGC)-related gene PRDM1 (BLIMP1) was strongly
expressed in small putative ovarian stem cells. In
both hESCs (p = 8.29E-03) and human adult fibroblasts
(p = 2.71E-04) PRDM1 was significantly down-regulated
at the log ratio < −4 in comparison with ovarian stem
cells, as revealed by DGAs. In addition putative ovarian
stem cells expressed PRDM14, but the expression of
this gene was up-regulated in hESCs (p = 6.41E-03)
and down-regulated in fibroblasts (p = 6.94E-03). The
DPPA3 (STELLA) gene was expressed in small putative
ovarian stem cells, but it was significantly up-regulated
in hESCs (p = 2.79E-07).
Expression of genes related to germinal lineage
In the FACS-sorted SSEA-4-positive small putative ovar-
ian stem cells and hESCs several genes related to germi-
nal lineage were expressed. When both groups of cells
were compared, some germinal lineage-related genes,
such as DPPA3 (STELLA), KIT, DNMT3B, MSH4,
BNC2, DIAPH2 and NR6A1 were up-regulated in hESCs.
On the other hand, some other germinal lineage-related
genes, such as VASA (DDX4) and PLD6 were down-
regulated in hESCs in comparison with small putative
ovarian stem cells, as can be seen in Additional file 1:
Table S2. These genes were not expressed or were weakly
expressed in adult human fibroblasts. In fibroblasts tran-
scription factor OVOL1, critical for oogenesis and
Figure 12 Heatmap expressions (excerpt) of genes up-regulated in human embryonic stem cells (hESCs), including genes related to
pluripotency, in comparison with FACS-sorted small putative ovarian stem cells (OSCs), with non-sorted ovarian cell cultures, released
from the culture dish bottom with trypsinisation (S) and with human adult fibroblasts (FBs).
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high confidence down-regulated in comparison with
FACS-sorted SSEA-4-positive small putative ovarian stem
cells (fold change −32.760, p = 2.92E-03).
Genes down-regulated in hESCs in comparison with small
putative ovarian stem cells
According to the DGA (hESCs vs. OSCs) there were
341 genes, which were with high statistical confidence
down-regulated in hESCs when compared to FACS-sorted
SSEA-4-positive small putative ovarian stem cells (OSCs).
When the character of these genes was inspected, down-
regulation of imprinted maternally expressed H19 was
found and at least 75 other genes were found to be relatedto oncogenesis (e.g. S100P, NOX4, WNT5B, BRIP1, NRP2,
CHD13, CPA4, ABLIM3, MGLL, FGF7), tumor suppres-
sion or reduction of metastatic potential (e.g. MPP1,
SERPINB8, PML, DLEU2L, MXI1, YAP1, INTS6, GPNMB,
CAV2), transcription regulation (e.g., PITX1, HOXA11,
FOXC1, PML, FOXO4, ZBTB26, HMBOX1, ZNF41,
PHTF2, MXI1, YAP1, MBD2, ZNF518B), embryogenesis
(e.g. WNT5B, FOXC1, PML, ABLIM3, ACVR1, FGF7,
IL6ST), cellular processes such as cell survival/death
(apoptosis), proliferation, division, differentiation and cell
cycle progression (e.g. TGM2, S100P, ARHGDIB, NOX4,
MPP1, WNT5B, SPDYA, CDK8, SERPINB8, PML,
DAAM1, FOXO4, TGFB2, CFLAR, CCNY, CSNK1G3,
DYRK4, PARVA, YAP1, ZNF703, SEPT8, CACNA1C,
Figure 13 The expressions of genes (normalized and log2-transformed intensities) related to pluripotency, embryonic stem cells and
embryogenesis in FACS-isolated small putative ovarian stem cells (OSCs) in comparison with human embryonic stem cells (hESCs) and
fibroblasts (FBs).
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some X (XIST), morphogenesis (HOXD9, FRY, FGF7,
UACA), left-right organ asymmetry (PITH1) and tissue
repair (LUM). Among genes related to development of
tissues and organs, the genes involved in neural develop-
ment (e.g. FRMPD4, PITX1, FRY, MPP1, SMARCA2,
PML, CDH13, FAM114A1, SPON2, PLXNB3, PCDHGB4,
ZNF703, SEMA5A, NRP2) predominated, followed by
genes related to the development of the cardiovascularsystem (e.g. PECAM1, NRP2, ANGPT1, FBLN5,
ANGPT1), ovaries (FOXL2), endometrium (HOXA11),
lungs (FGF7), myoblasts (PPAPDC3), lymphocytes
(e.g. NT5E, MR1, STAM) and development of
hematopoiesis (RUNX1). The character of these genes
might be related to the degree of stemness. Several of
these genes were down-regulated or were not
expressed in human adult fibroblasts. The locations
and functions of genes down-regulated in hESCs in
Table 1 Differences in the expressions of genes
(normalized and log2-transformed intensities) related to
pluripotency, embryonic stem cells and embryogenesis in
FACS-isolated small putative ovarian stem cells (OSCs) in
comparison with fibroblasts (FBs) revealed using the
Student’s T test
Log fold change p-value Adj. p-value
POU5F1 0.78 0.122520121 1.64E-01
SALL4 ** 5.41 0.000714457 2.23E-03
CDH1 ** 3.21 0.018838123 3.21E-02
LIN28B ** 5.11 0.005075958 1.06E-02
NANOG 0.86 0.552979106 6.08E-01
SOX2 −2.15 0.023394118 3.87E-02
SOX11 ** 2.90 0.000290721 1.18E-03
DPPA3 −2.19 0.048897088 7.36E-02
LEFTY1 ** 4.23 0.000384105 1.42E-03
ZIC3 ** 3.79 9.29E-05 5.66E-04
ZIC5 −0.63 0.090116973 1.25E-01
PRDM14 ** 3.63 0.003039563 6.94E-03
GAL 1.58 0.26269284 3.19E-01
PPP1R9A ** 1.55 0.006663692 1.33E-02
SMO −0.68 0.545353659 6.01E-01
MMP25 * −2.43 0.006783372 1.35E-02
MLLT4 −1.10 0.211498682 2.64E-01
BMP7 0.73 0.515756119 5.73E-01
MYBL2 ** 2.35 0.006965786 1.38E-02
DNMT3B ** 2.64 0.000957838 2.79E-03
ZFP42 1.05 0.148285014 1.94E-01
HESRG ** 6.89 0.000200358 9.14E-04
ZSCAN10 1.37 0.130067706 1.73E-01
TRO −1.13 0.456996609 5.17E-01
DDX11 −2.57 0.015893686 2.78E-02
P-values were adjusted for the effect of multiple testing according to
Benjamini-Hochberg (limma, Bioconductor, programme R 2.14.1). Statistical
significance was set at p < 0.05. Legend: ** – genes up-regulated in OSCs,
* – genes down-regulated in OSCs.
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described in Additional file 1: Table S3.
Genes up-regulated in hESCs in comparison with small
putative ovarian stem cells
On the other hand there were 435 genes which were at a
high statistical confidence up-regulated in hESCs in com-
parison with FACS-sorted SSEA-4-positive small putative
ovarian stem cells (OSCs), as revealed by DGA analysis
(hESCs vs. OSCs). Among these genes there were several
genes related to pluripotency, cell self-renewal, embryonic
development and implantation, as already described above
(Figure 12). The locations and functions of genes up-
regulated in hESCs in comparison with small putative
ovarian stem cells are described in the Additional file 1:Table S4. Among other genes, some imprinted genes, such
as SNRPN, PPP1R9A and DNMT3B were up-regulated in
hESCs. From the heatmap presenting the expression of
genes up-regulated in hESCs it can be seen that the
FACS-sorted SSEA-4-positive small putative ovarian stem
cells significantly expressed several genes related to
pluripotency and embryogenesis, while human adult
fibroblasts did not express or weakly expressed most of
genes, which were up-regulated in hESCs (Figure 12).
Comparison of fibroblasts to small putative ovarian stem cells
When human adult fibroblasts were compared to small pu-
tative ovarian stem cells, the proportion of differently
expressed genes was significantly higher than in hESCs.
Fibroblasts had 239 down-regulated genes and 1,084 up-
regulated genes in comparison with FACS-isolated SSEA-
4-positive small putative ovarian stem cells, as revealed by
DGA analysis (FBs vs. OSCs). In fibroblasts the gene
PROM1 encoding the surface antigen CD133 was signifi-
cantly down-regulated (p = 3.78E-02) at the log ratio < −4
in comparison with ovarian stem cells, as revealed by DGA.
Moreover, in fibroblasts the imprinted maternally expressed
H19 and paternally expressed IGF2 were down-regulated.
As can be seen in Figures 12 and 13, the fibroblasts did not
express or only weakly expressed a variety of genes related
to pluripotency. There were several genes related to
pluripotency and embryogenesis (e.g. PTX1, SALL4,
DPPA5, ELF3, FGF9, the SOX-family of genes: SOX3,
SOX6, SOX14, SOX15, SOX30), morphogenesis (e.g.
HOXD11, FGF9), cell cycle and cell survival regulation
(CDCA3, CENPM, DTL, NOX4, E2F2), transcriptional
regulation (ZNF114, E2F2, ELF3, HOXD11, OVOL1), cell
growth, differentiation and development (IGF2, FGF9,
OVOL1, CGA, ESRRB, E2F2), tumorigenesis/cancer (ELF3,
NOX4, FGF9, E2F2, SP140, DIRC3, TNFAIP6, LOC349160,
BAALC, VWCE), tumor suppression (H19, EF2F) and
gametogenesis (OVOL1), all of which were with high
statistical confidence down-regulated in fibroblasts in
comparison to FACS-isolated small putative ovarian stem
cells, as can be seen in Additional file 1: Table S5. Similar
to hESCs, the putative ovarian stem cells did not express
several genes among those which were up-regulated in
human fibroblasts (Figure 14).
Comparison of all groups of analyzed cells
The FACS-isolated SSEA-4-positive small putative ovarian
stem cells showed lower general gene expression profile
than hESCs and fibroblasts which may be related to a more
quiescent state. In spite of that, FACS-isolated small
putative ovarian stem cells expressed several genes related
to pluripotency and embryogenesis which were mostly up-
regulated in hESCs. As can been seen in the Additional
file 1: Table S6, this reflects in predominating cellular
processes, expressed in these two types of cells, such as cell
Figure 14 Heatmap expressions (excerpt) of genes up-regulated
in human adult fibroblasts (FBs) in comparison with FACS-sorted
small putative ovarian stem cells (OSCs), human embryonic stem
cells (hESCs) and with non-sorted ovarian stem cell cultures,
released from the culture dish bottom with trypsinisation (S).
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tion and post-translational modification, as revealed by IPA
(Ingenuity) analysis. The fibroblasts did not express or were
down-regulated for several genes related to pluripotency
and embryogenesis (Figures 12 and 13, Additional file 1:
Table S5), and were more related to other cellular
processes, such as cell-to-cell signaling and interaction,
cellular movement, vitamin and mineral metabolism, anti-
gen presentation and cellular development (Additional
file 1: Table S6). Although FACS-isolated SSEA-4-positive
small putative ovarian stem cells showed a relatively low
general gene expression profile, IPA (Ingenuity) analysisrevealed networks of genes related to organism develop-
ment, skeletal and muscular system development and
function, and embryonic development, which were down-
regulated in hESCs, as well as networks of genes related to
cellular growth and proliferation, organ morphology and
tissue morphology which were down-regulated in human
fibroblasts, as compared to the OSCs (Figure 15).
In hESCs and small putative ovarian stem cells other
transcription regulators were expressed differently (e.g.
predominately MYC-up-regulated in hESCs, TP53-down-
regulated-inhibited-in hESCs,TP63-up-regulated in hESCs,
AR-down-regulated in hESCs, IRF8-down-regulated in
hESCs, RAR, SMAD2/3-SMAD4, VITAMIND3-VDR-RXR,
and NFAT family), than in somatic fibroblasts and
small putative ovarian stem cells (e.g. predominately
SATB1-inhibited in fibroblasts, RAR ligand-RARα-Retinoic
acid-RXRα, RXR, PROP1, SOX11, SOX12, E2F7, LHX3).
All this data confirmed the different molecular charac-
ter of analyzed cells.
RT-PCR analyses of small putative ovarian stem cells in
comparison with hESCs and human adult fibroblasts
Putative ovarian stem cells and hESCs strongly expressed
all analyzed genes (LEFTY1, SALL4, OCT4A, TDGF1,
REC8, CDH1, STELLA) related to pluripotency and embry-
onic stem cells, while human adult fibroblasts (FBs)
extremely weakly expressed genes LEFTY1, SALL4, CDH1
and STELLA (Figure 16). In addition, fibroblasts expressed
genes SALL4 (p = 0.0059) and REC8 (p = 0.0001) to a
significantly lower extent than putative ovarian stem cells
(OSCs), as revealed by Student’s T-test (Figure 17). Two
samples of putative ovarian stem cells (Samples 1 and 2)
clustered together with hESCs and were separated from
fibroblasts (Figure 16), as revealed by heatmap, dendrogram
and principal component analysis. On the other hand, one
sample of putative ovarian stem cells (Sample 3) clustered
with fibroblasts, which indicates the potential heterogeneity
of putative ovarian stem cell samples in terms of
pluripotency. These data confirmed the microarray data
which similarly showed the up-regulation of genes LEFTY1,
SALL4 and CDH1 in putative ovarian stem cells in com-
parison with human adult fibroblasts.
Discussion
We found that in human adult ovarian cell cultures there
was a population of small, round, yellow-coloured cells with
diameters of up to 4 μm observed during culturing and
after isolation by FACS, based on SSEA-4 expression. In
testicular and hESC cell cultures there was a similar popu-
lation of small, round, yellow-coloured SSEA-4-positive
cells with diameters of up to 4 μm, isolated by FACS. The
expression of SSEA-4 surface antigen makes them puta-
tive stem cells. The presence of these small cells –
putative stem cells – has already been published by our
Figure 15 Gene networks down-regulated in human embryonic stem cells and fibroblasts in comparison with FACS-isolated small
putative ovarian stem cells. (A) Network of genes related to organism development, skeletal and muscular system development and function,
and embryonic development, which were down-regulated in hESCs. (B) Network of genes related to cellular growth and proliferation, organ
morphology, and tissue morphology which were down-regulated in human fibroblasts.
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cultures [18,22], but to our knowledge this is the first
time they are reported in hESC cultures.
Small round putative ovarian stem cells may be compar-
able to VSELs in terms of their morphology, shape and
diameters [1], although they seem to be an integral part ofthe ovaries [18] and not “contaminant” from the blood
stream. Surprisingly, these cells were also present and
sorted from the hESC cultures. This opens the possible
question if these cells are the “real” embryonic stem cells,
which may persist in adult human ovaries and testicles
from the embryonic period of life – from the time of
Figure 16 Small putative ovarian stem cells (OSC1-3: violet) expressed genes related to pluripotency and embryonic stem cells when
compared to hESCs (ESC1-3: aquamarine) and human adult (dermal) fibroblasts (FB1-3: gray), as revealed by RT-PCR (Fluidigm). Two
OSC samples clustered with hESCs and one OSC sample clustered with fibroblasts. (A) Heatmap clustering; (B) Hierarchical clustering; (C) Principal
component analysis (PCA).
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tential presence of cells with embryonic-like character in
adult human gonads, ovaries and testicles. After FACS-
sorting a proportion of small round putative stem cells
spontaneously grew into bigger cells with diameters of up
to 10 μm.
For ESCs it has been believed that they most closely
resemble pluripotent primitive ectoderm cells derived
directly from the inner cell mass of blastocysts. How-
ever, differences between ESCs and primitive ectoderm
cells have opened the question whether ESCs really have
an in vivo equivalent or whether their properties mostlyreflect their artificial tissue culture environment. In fact,
we do not currently know what the natural embryonic
stem cells look like.
Microarray data show that FACS-isolated SSEA-4-
positive small, round, yellow-coloured cells isolated from
the adult ovarian tissue cell cultures express several
genes related to adult stem cells, primordial germ cells,
pluripotency, embryogenesis, implantation and develop-
ment; therefore, we propose that they are putative stem
cells. In fibroblasts the gene PROM1 encoding the CD133
surface antigen was significantly down-regulated in com-
parison with small putative ovarian stem cells. CD133 is
Figure 17 Descriptive statistics of the expression of genes related to pluripotency and embryonic stem cells by putative ovarian stem
cells (OSC1-3: violet) in comparison with hESCs (ESC1-3: aquamarine) and human adult fibroblasts (FB: gray), revealed by RT-PCR
(Fluidigm) showing that putative ovarian stem cells and hESCs strongly expressed all analyzed genes, while fibroblasts only weakly
expressed them (except OCT4A). In addition, fibroblasts expressed the genes SALL4 and REC8 to a significantly lower extent than OSCs, as
revealed by the Student’s T-test.
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cells, such as hematopoietic stem cells [28] and in VSELs
from human umbilical cord blood [10], and is related to
the manifestation of different cancers, including ovarian
cancer [29]. Primordial germ cell (PGC)-related genes
PRDM1 (BLIMP1) and PRDM14 were strongly expressed
in small putative ovarian stem cells. The PRDM1 gene is
the key determinant of PGCs and plays a crucial role
together with PRDM14 during PGC specification from
postimplantation epiblast cells [30]. Moreover, PRDM1 is
a critical determinant of germ cell lineage in mice. The
experiments indicated that the PRDM1-positive cells orig-
inated from the proximal posterior epiblast cells and were
indeed the lineage-restricted PGC precursors [31]. The
small putative ovarian stem cells also expressed the
DPPA3 gene. Therefore, the relation of small putative
stem cells from the adult ovarian surface epithelium to
PGCs or their precursors is not excluded. The microarray
data also show a specific pattern of expression of genes
related to pluripotency and embryogenesis with several
genes down-regulated in comparison with hESCs and
others up-regulated in comparison with fibroblasts. In
spite of that, these small putative ovarian stem cells show
a different, more quiescent gene expression profile than
hESCs analyzed in this study. This may reflect the fact that
they were isolated from adult ovarian cortex tissues and
not from human embryos, and that they passed through
the procedure of FACS isolation. It is not excluded that
these small putative ovarian stem cells are in a more
quiescent stage in comparison with other analyzed cells(hESCs, fibroblasts), as already published for some other
types of stem cells, such as hematopoietic stem cells [32]
and cancer stem cells [33]. This “dormant” stage may en-
able them to persist in adult tissues until they are needed
for regeneration. Small putative ovarian stem cells showed
completely different gene expression profiles than human
fibroblasts, which did not express several genes
related to pluripotency, embryogenesis and development,
or were down-regulated for them. The small size of the
putative stem cells from adult gonads (up to 4 μm) com-
parable to VSELs from human bone marrow or umbilical
cord blood with diameters of ~5–6 μm could probably be
explained by their highly quiescent status.
It is necessary to expose the down-regulation of
epigenetically-regulated genes H19 and IGF2 in fibroblasts
and the down-regulation of H19 in hESCs in comparison
with small putative ovarian stem cells in this study. This
may only be in partial accordance with the previous finding
in bone marrow-derived VSELs that confirmed the up-
regulation of H19 and down-regulation of IGF2 in VSELs
[25]. It has been proposed that the up-regulation of H19 in
VSELs might be involved in the maintenance of the quies-
cent stage and prevention of teratoma formation in adult
tissues [25]. Small putative ovarian stem cells expressed a
specific pattern of up-regulated genes related to
pluripotency and embryonic stem cells, including genes
SALL4, LEFTY1, CDH1, ZIC3 and HESRG. The stem cell
gene SALL4 is well characterized for its essential role in
developmental events as well as embryonic stem cell
pluripotency maintenance. This gene was confirmed to
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cells and differentiation of postnatal spermatogonial
progenitor cells [34]. It is also expressed in hematopoietic
stem cells and represents a key regulator in normal human
hematopoiesis [35]. This might reflect the same (mesoder-
mal) origin of both the ovaries and circulatory system
(including hematopoietic stem cells), and the same progeni-
tor cells; it is not excluded that the progenitor cells may
circulate in the blood stream. In addition, the CDH1
(e-cadherin) is known to be the late premeiotic germ cell
marker [36]. The character of small putative stem cells in
reproductive tissues needs to be further researched to make
a real conclusion.
Interestingly, there were several genes related to germinal
lineage expressed in both the hESCs and small putative
ovarian stem cells. Most of them were up-regulated in
hESCs, while the genes VASA and PLD6 were up-regulated
in small putative ovarian stem cells. Gene PLD6 is required
for gametogenesis and promotes the recruitment and/or
activation of components of the meiotic nuage [37].
Additionally, a proportion of cell colonies and small round
cells – putative stem cells – in all cell cultures, regardless of
origin, were stained VASA-positive. The gene VASA is a
germinal lineage-associated gene, which is expressed in
human gametes [38]. The VASA-staining was reasonable
because the possible germ cell origin of hESCs has already
been suggested [39], and it is not excluded that the oocyte
represents a real source of “embryonic” stem cells. Little is
known about the VASA expression and expression of other
germinal lineage-related genes in pluripotent stem cells.
Some studies revealed the expression of germinal lineage-
related genes, including VASA, by ESCs in primates [40].
Therefore the germ cell origin of both hESCs and small
putative stem cells from reproductive tissues cannot be
excluded.Additional files
Additional file 1: Table S1. FACS-isolated, SSEA-4-positive, small putative
ovarian stem cells (OSCs) expressed several genes related to pluripotency, cell
self-renewal, embryonic development and implantation. All of these genes
were up-regulated in hESCs at a high statistical confidence, as revealed by
DGA analysis (hESCs vs. OSCs). Table S2. FACS-isolated, SSEA-4-positive, small
putative ovarian stem cells (OSCs) expressed some germinal lineage-related
genes. Most of these genes were up-regulated in hESCs at a high statistical
confidence with the exception of genes DDX4 (VASA) and PLD6, which were
down-regulated in hESCs, as revealed by DGA analysis (hESCs vs. OSCs). Most
of these genes were not expressed in human fibroblasts when compared to
OSCs. Table S3. Genes down-regulated in human embryonic stem cells in
comparison with FACS-isolated, SSEA-4-positive, small putative ovarian stem
cells at a high statistical confidence. Legend: *– genes downregulated in
human fibroblasts at a high statistical confidence, **– genes down-regulated
in human fibrobalsts at a statistical significance of log ratio < -4. Table S4.
Genes which were at a high statistical confidence up-regulated in human
embryonic stem cells in comparison with FACS-isolated, SSEA-4-positive, small
putative ovarian stem cells. Table S5. Genes which were at a high statistical
confidence down-regulated in human fibroblasts in comparison with
FACS-isolated, SSEA-4-positive, small putative ovarian stem cells.Table S6. Genes differently expressed in human embryonic stem cells (hESCs)
and FACS-isolated, SSEA-4-positive, small putative ovarian stem cells (OSCs)
showed different relations to associated network functions, diseases and
disorders, molecular and cellular functions, physiological system development
and function and top canonical pathways than genes differently expressed in
fibroblasts and OSCs.
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